Analystreport

Edwards Lifesciences (NYSE: EW) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $140.00 price target on the stock.

Edwards Lifesciences Corporation  (EW) 
Last edwards lifesciences corporation earnings: 4/23 04:15 pm Check Earnings Report
US:NYSE Investor Relations: ir.edwards.com